IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,935,281 | +367.3% | 64,711 | +322.7% | 0.01% | +400.0% |
| Q2 2023 | $628,188 | -61.7% | 15,310 | -66.7% | 0.00% | -66.7% |
| Q1 2023 | $1,641,362 | -5.4% | 45,924 | -0.0% | 0.00% | -25.0% |
| Q4 2022 | $1,735,297 | +105.4% | 45,941 | +140.2% | 0.00% | +100.0% |
| Q3 2022 | $845,000 | +115.6% | 19,129 | +80.0% | 0.00% | +100.0% |
| Q2 2022 | $392,000 | -3.7% | 10,626 | -3.6% | 0.00% | 0.0% |
| Q1 2022 | $407,000 | +20.1% | 11,018 | -1.6% | 0.00% | 0.0% |
| Q4 2021 | $339,000 | -15.5% | 11,194 | -19.8% | 0.00% | 0.0% |
| Q3 2021 | $401,000 | -18.5% | 13,957 | -0.7% | 0.00% | 0.0% |
| Q2 2021 | $492,000 | -64.3% | 14,052 | -48.8% | 0.00% | -66.7% |
| Q1 2021 | $1,377,000 | -5.9% | 27,462 | +3.0% | 0.00% | -25.0% |
| Q4 2020 | $1,463,000 | -63.5% | 26,651 | -68.7% | 0.00% | -66.7% |
| Q3 2020 | $4,013,000 | -27.4% | 85,131 | -9.5% | 0.01% | -29.4% |
| Q2 2020 | $5,529,000 | +29.2% | 94,051 | +3.9% | 0.02% | +6.2% |
| Q1 2020 | $4,278,000 | -28.2% | 90,483 | -8.3% | 0.02% | -11.1% |
| Q4 2019 | $5,962,000 | +37.9% | 98,697 | +36.8% | 0.02% | +63.6% |
| Q3 2019 | $4,322,000 | -2.6% | 72,142 | +4.5% | 0.01% | -21.4% |
| Q2 2019 | $4,437,000 | -18.7% | 69,041 | +2.7% | 0.01% | -22.2% |
| Q1 2019 | $5,459,000 | +94.3% | 67,249 | +23.4% | 0.02% | +80.0% |
| Q4 2018 | $2,810,000 | 0.0% | 54,477 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $2,810,000 | -32.0% | 54,477 | -45.1% | 0.01% | -28.6% |
| Q2 2018 | $4,134,000 | +24.0% | 99,205 | +31.2% | 0.01% | +7.7% |
| Q1 2018 | $3,334,000 | +17.6% | 75,633 | +34.1% | 0.01% | +30.0% |
| Q4 2017 | $2,836,000 | +0.1% | 56,395 | +1.0% | 0.01% | 0.0% |
| Q3 2017 | $2,832,000 | +8.4% | 55,849 | +8.7% | 0.01% | 0.0% |
| Q2 2017 | $2,613,000 | +61.5% | 51,357 | +27.6% | 0.01% | +42.9% |
| Q1 2017 | $1,618,000 | -6.6% | 40,237 | +11.1% | 0.01% | -12.5% |
| Q4 2016 | $1,732,000 | -63.1% | 36,207 | -71.7% | 0.01% | -66.7% |
| Q3 2016 | $4,693,000 | +49.9% | 128,085 | -4.7% | 0.02% | +26.3% |
| Q2 2016 | $3,131,000 | +85.2% | 134,430 | +222.0% | 0.02% | +72.7% |
| Q1 2016 | $1,691,000 | +1116.5% | 41,754 | +1764.0% | 0.01% | +1000.0% |
| Q4 2015 | $139,000 | – | 2,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |